Inhibitors Of Activated Stats
Inhibitors Of Activated Stats - Related Videos
01:52
Eukaryotic Transcription Inhibitors
0 Views •
2020
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells. Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:20
The JAK-STAT Signaling Pathway
0 Views •
2023
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
0 Views •
Cited by 3 •
2025
This study used in-silico strategies to identify Enumerated Etravirine as a promising therapeutic agent for HIV. Our findings on molecular interactions and dynamics support the rational design of novel NNRTIs as possible HIV treatment alternatives.
04:00
Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model
0 Views •
2023
This video demonstrates the in vivo delivery of miRNA inhibitors as therapeutic agents against tumor growth in orthotopic mouse models. The intratumoral administration of synthetic miRNA inhibitors or antagomiRs allows them to bind and inhibit endogenous miRNAs, thereby causing mRNA upregulation and suppression of tumor growth.
05:46
Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
0 Views •
2025
This protocol describes a gel shift biochemical assay for measuring FEN1 (Flap Endonuclease 1) activity and inhibitor development.
FAQs
PIAS proteins act downstream of receptor-associated Janus kinases, after STAT phosphorylation and dimer formation have occurred. By associating with activated STAT dimers, they can reduce the dimers’ ability to drive target-gene transcription without serving as the primary block to receptor-to-STAT activation. This places PIAS-mediated restraint at the transcriptional control stage of signaling.
PIAS proteins can influence activated STAT dimers through more than direct association. In some contexts, they promote SUMOylation, the attachment of SUMO regulatory groups, or recruit transcriptional coregulators. These mechanisms provide additional ways to modify transcriptional activity, helping explain why PIAS effects may depend on the cellular signaling context rather than follow one uniform outcome.
Upstream inhibition would limit events such as receptor-associated Janus kinase activity, STAT phosphorylation, or dimer formation. PIAS proteins act later, when activated STAT dimers can already enter the nucleus and engage target DNA. This distinction separates control of signal initiation from control of STAT-dependent gene expression and helps identify where signaling restraint occurs.
Because PIAS proteins act after STAT activation, they can regulate the transcriptional consequences of cytokine and growth-factor signaling rather than simply preventing the signal from starting. This timing is important when evaluating inflammatory, immune, or proliferative responses, since altered PIAS activity may change how strongly activated STATs influence gene expression in those settings.
A useful analysis follows the pathway from receptor-associated Janus kinase activity through STAT phosphorylation, dimerization, nuclear entry, DNA binding, and PIAS-mediated transcriptional restraint. Comparing these stages helps distinguish excessive upstream activation from inadequate control at the transcriptional stage. The resulting interpretation can clarify how altered PIAS activity contributes to abnormal cellular responses.
PIAS proteins are relevant to developmental biology, immune disorders, and cancer research. In development, they help frame questions about regulated signaling responses. In immune disease and cancer, their importance follows from the possibility that abnormal JAK-STAT signaling can promote inappropriate inflammatory, immune, or proliferative effects. These areas therefore connect molecular regulation with broader biological outcomes.
Altered PIAS activity can point to disrupted control of STAT-dependent gene expression, particularly when inflammatory, immune, or proliferative responses are abnormal. It provides a regulatory perspective alongside the study of JAK-STAT activation itself. In disease research, examining this control point may help explain how signaling that is normally limited becomes associated with immune disorders or cancer-related processes.